表纸
市场调查报告书

永久性人造皮肤的全球市场:2019年~2023年

Global Permanent Artificial Skin Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品编码 781942
出版日期 内容资讯 英文 120 Pages
订单完成后即时交付
价格
永久性人造皮肤的全球市场:2019年~2023年 Global Permanent Artificial Skin Market 2020-2024
出版日期: 2020年03月19日内容资讯: 英文 120 Pages
简介

提高对提供皮肤和组织的认识的配合措施增加。如Donate Life America这样的组织,开展越来越多的提高认识计划,以提高对需要更换手术和皮肤捐赠需求的皮肤疾病的认识。Donate Life America是一家非营利组织,致力于捐赠器官,眼睛和组织。该组织与其他组织(如美国组织银行协会)合作,向全美人群宣传组织捐赠,并鼓励人们捐赠组织。Technavio的分析师预测,到2023年,永久性人造皮肤市场的年复合成长率将达到近19%。

本报告提供全球永久的人造皮肤市场相关调查分析,市场规模与成长率,市场趋势,市场的推动要素与课题,市场机会验证,再加上主要供应商等相关的系统性资讯。

目录

第1章 摘要整理

第2章 报告的范围

  • 简介1
  • 简介2
  • 美金的货币换算比率

第3章 市场情形

  • 市场生态系统
  • 市场特征
  • 市场区隔分析

第4章 市场规模

  • 市场定义
  • 市场规模(2018年)
  • 市场规模及预测(2018年~2023年)

第5章 波特的五力分析

  • 买主谈判力
  • 供应商谈判力
  • 新加入厂商的威胁
  • 替代品的威胁
  • 竞争对手的威胁
  • 市场情况

第6章 市场区隔:各终端用户

  • 市场区隔:各终端用户
  • 各终端用户比较:市场规模及预测(2018年~2023年)
  • 医院
  • 其他医疗保健中心
  • 市场机会:各终端用户

第7章 客户形势

第8章 地区形势

  • 各地区市场区隔
  • 各地区比较:市场规模及预测(2018年~2023年)
  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区
  • 主要国家
  • 市场机会

第9章 决策架构

第10章 成长要素与课题

  • 市场成长要素
  • 市场课题

第11章 市场趋势

  • 技术的进步
  • 策略性联盟
  • 提高提供皮肤和组织的认识的配合措施增加

第12章 业者情势

  • 概要
  • 创造性破坏状况

第13章 供应商分析

  • 交易厂商
  • 供应商分类
  • 供应商的市场定位
  • Avita Medical
  • EUCARE PHARMACEUTICALS
  • Integra LifeSciences
  • MiMedx
  • Solsys Medical

第14章 附录

  • 调查方法
  • 简称的清单

第15章 关于TECHNAVIO

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: IRTNTR41631

Technavio has been monitoring the global permanent artificial skin market and it is poised to grow by USD 4.41 bn during 2020-2024, progressing at a CAGR of 19% during the forecast period. Our reports on global permanent artificial skin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in R&D funding. In addition, availability of cost-effective treatment in developing countries is anticipated to boost the growth of the global permanent artificial skin market as well.

Market Segmentation

Technavio's ‘ global permanent artificial skin market ’ is segmented as below:

End-User:

  • Hospitals
  • Other Healthcare Centers

Geographic segmentation

  • North America
  • Europe
  • APAC
  • ROW

Key Trends for global permanent artificial skin market growth

This study identifies availability of cost-effective treatment in developing countries as the prime reasons driving the global permanent artificial skin market growth during the next few years.

Prominent vendors in global permanent artificial skin market

We provide a detailed analysis of around 25 vendors operating in the global permanent artificial skin market 2020-2024, including some of the vendors such as AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc. and Smith & Nephew Plc .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AVITA Medical Ltd.
  • Aroa Biosurgery Ltd.
  • Eucare Pharmaceuticals Pvt. Ltd.
  • Integra LifeSciences Corp.
  • Mallinckrodt Plc
  • MedSkin Solutions Dr. Suwelack AG
  • MiMedx Group Inc.
  • Misonix Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Market in focus
  • 9.Parent market
  • 12.Market characteristics
  • 14.Offerings of vendors included in the market definition
  • 16.Market segments
  • 21.Global - Market size and forecast 2019 - 2024 ($ million)
  • 22.Global market: Year-over-year growth 2019 - 2024 (%)
  • 23.Five forces analysis 2019 & 2024
  • 25.Bargaining power of buyers
  • 26.Bargaining power of suppliers
  • 27.Threat of new entrants
  • 28.Threat of substitutes
  • 29.Threat of rivalry
  • 31.Market condition - Five forces 2019
  • 32.Customer landscape
  • 33.Market share by geography 2019-2024 (%)
  • 34.Geographic comparison
  • 36.North America - Market size and forecast 2019-2024 ($ million)
  • 37.North America - Year-over-year growth 2019-2024 (%)
  • 39.Europe - Market size and forecast 2019-2024 ($ million)
  • 40.Europe - Year-over-year growth 2019-2024 (%)
  • 42.APAC - Market size and forecast 2019-2024 ($ million)
  • 43.APAC - Year-over-year growth 2019-2024 (%)
  • 45.ROW - Market size and forecast 2019-2024 ($ million)
  • 46.ROW - Year-over-year growth 2019-2024 (%)
  • 47.Key leading countries
  • 48.Market opportunity by geography ($ million)
  • 49.Impact of drivers and challenges
  • 50.Vendor landscape
  • 52.Landscape disruption
  • 54.Industry risk
  • 56.Vendors covered
  • 58.Market positioning of vendors
  • 60.AVITA Medical Ltd. - Overview
  • 61.AVITA Medical Ltd. - Business segments
  • 62.AVITA Medical Ltd. - Key offerings
  • 63.AVITA Medical Ltd. - Key customers
  • 64.AVITA Medical Ltd. - Segment focus
  • 66.Aroa Biosurgery Ltd. - Overview
  • 67.Aroa Biosurgery Ltd. - Product and service
  • 68.Aroa Biosurgery Ltd. - Key offerings
  • 69.Aroa Biosurgery Ltd. - Key customers
  • 70.Aroa Biosurgery Ltd. - Segment focus
  • 72.Eucare Pharmaceuticals Pvt. Ltd. - Overview
  • 73.Eucare Pharmaceuticals Pvt. Ltd. - Product and service
  • 74.Eucare Pharmaceuticals Pvt. Ltd. - Key offerings
  • 75.Eucare Pharmaceuticals Pvt. Ltd. - Key customers
  • 76.Eucare Pharmaceuticals Pvt. Ltd. - Segment focus
  • 78.Integra LifeSciences Corp. - Overview
  • 79.Integra LifeSciences Corp. - Business segments
  • 80.Integra LifeSciences Corp. - Key offerings
  • 81.Integra LifeSciences Corp. - Key customers
  • 82.Integra LifeSciences Corp. - Segment focus
  • 84.Mallinckrodt Plc - Overview
  • 85.Mallinckrodt Plc - Business segments
  • 86.Mallinckrodt Plc - Key offerings
  • 87.Mallinckrodt Plc - Key customers
  • 88.Mallinckrodt Plc - Segment focus
  • 90.MedSkin Solutions Dr. Suwelack AG - Overview
  • 91.MedSkin Solutions Dr. Suwelack AG - Product and service
  • 92.MedSkin Solutions Dr. Suwelack AG - Key offerings
  • 93.MedSkin Solutions Dr. Suwelack AG - Key customers
  • 94.MedSkin Solutions Dr. Suwelack AG - Segment focus
  • 96.MiMedx Group Inc. - Overview
  • 97.MiMedx Group Inc. - Business segments
  • 98.MiMedx Group Inc. - Key offerings
  • 99.MiMedx Group Inc. - Key customers
  • 100.MiMedx Group Inc. - Segment focus
  • 102.Misonix Inc. - Overview
  • 103.Misonix Inc. - Business segments
  • 104.Misonix Inc. - Key offerings
  • 105.Misonix Inc. - Key customers
  • 106.Misonix Inc. - Segment focus
  • 108.Organogenesis Holdings Inc. - Overview
  • 109.Organogenesis Holdings Inc. - Business segments
  • 110.Organogenesis Holdings Inc. - Key offerings
  • 111.Organogenesis Holdings Inc. - Key customers
  • 112.Organogenesis Holdings Inc. - Segment focus
  • 114.Smith & Nephew Plc - Overview
  • 115.Smith & Nephew Plc - Business segments
  • 116.Smith & Nephew Plc - Key offerings
  • 117.Smith & Nephew Plc - Key customers
  • 118.Smith & Nephew Plc - Segment focus
  • 120.Currency conversion rates for US$
  • 121.Research Methodology
  • 122.Validation techniques employed for market sizing
  • 123.Information sources
  • 124.List of abbreviations